MedPath

Reducing the menstrual pain by herbal formulation

Phase 3
Not yet recruiting
Conditions
Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,
Registration Number
CTRI/2025/04/086042
Lead Sponsor
OTHER
Brief Summary

Primary Dysmenorrhea is a most common disorder that affects upto 70% of the female population. It affects patients with significant impairment in quality of life, sleep,and work performance because of pain. The prevalence of Primary Dysmenorrhea has increased in recent decades due to sedentary lifestyle and unhealthy food habits. Primary Dysmenorrhea can be compared with Udavartini in Ayurveda,which is one of the diseases caused by vitiation of vata and can be treated with vata anulomana drugs. In the proposed research,a short term and more palatable drug approach will be used to treat primary dysmenorrhea. This study aims to assess the effectiveness of interventions with internally administered herbal formulations for better outcomes in the treatment of primary dysmenorrhea.

The study is an exploratory study. A total of 40 patients fulfilling the inclusion criteria will be selected. The treatment protocol comprised Chaturbeeja arka 10 ml  for first three days of menstruation twice orally with equal quantity of water for one menstruation cycle. Patients will be assessed based on Vas score,Cox menstrual symptom scale and VMSS scale. The data will be statistically evaluated with friedman test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria

Regular menstrual cycles for three consecutive months having moderate to severe Primary Dysmenorrhea maintaining menstrual history diary or records.Those who have video calling facility on their mobile.

Exclusion Criteria

Participants with genitourinary infection, under hormonal therapy, diagnosed case of pelvic pathology, Plan for conception.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in intensity of pain using the vas scale.First three days of menstruation | for one menstrual cycle.
Secondary Outcome Measures
NameTimeMethod
Reduction in duration of pain and improvement in quality of life using CMSS and VMSS scale respectivelyfirst three days of menstruation cycle twice daily using video calls

Trial Locations

Locations (1)

Amrita Ayurveda Hospital,Amrita school of ayurveda

🇮🇳

Kollam, KERALA, India

Amrita Ayurveda Hospital,Amrita school of ayurveda
🇮🇳Kollam, KERALA, India
Dr Deepu Rani
Principal investigator
9756900088
deepu.rani23@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.